The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Open accessAbstract
T cells infiltrating inflammatory sites are usually of the activated/memory type. The precise mechanism for the positioning of these cells within tissues is unclear. Adhesion molecules certainly play a role; however, the intricate control of cell migration appears to be mediated by numerous chemokines and their receptors. Particularly important chemokines for activated/memory T cells are the CXCR3 ligands IP-10 and Mig and the CCR5 ligands RANTES, macrophage inflammatory protein-1alpha, and macrophage inflammatory protein-1beta. We raised anti-CXCR3 mAbs and were able to detect high levels of CXCR3 expression on activated T cells. Surprisingly, a proportion of circulating blood T cells, B cells, and natural killer cells also expressed CXCR3. CCR5 showed a similar expression pattern as CXCR3, but was expressed on fewer circulating T cells. Blood T cells expressing CXCR3 (and CCR5) were mostly CD45RO+, and generally expressed high levels of beta1 integrins. This phenotype resembled that of T cells infiltrating inflammatory lesions. Immunostaining of T cells in rheumatoid arthritis synovial fluid confirmed that virtually all such T cells expressed CXCR3 and approximately 80% expressed CCR5, representing high enrichment over levels of CXCR3+ and CCR5+ T cells in blood, 35 and 15%, respectively. Analysis by immunohistochemistry of various inflamed tissues gave comparable findings in that virtually all T cells within the lesions expressed CXCR3, particularly in perivascular regions, whereas far fewer T cells within normal lymph nodes expressed CXCR3 or CCR5. These results demonstrate that the chemokine receptor CXCR3 and CCR5 are markers for T cells associated with certain inflammatory reactions, particularly TH-1 type reactions. Moreover, CXCR3 and CCR5 appear to identify subsets of T cells in blood with a predilection for homing to these sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CCR5, another chemokine receptor with similar homing properties, has been also used to identify these cells [144, 145], but it is expressed only on the more differentiated Th1 effector memory population [146].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [145]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,574
Lymphocyte Homing and Homeostasis
Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,193
Self-citationThe lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark‐Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Oberlin, E., Amara, A., Bachelerie, F., Chable-Bessia, C., Virelizier, J., Arenzana‐Seisdedos, F., Schwartz, O., Heard, J., Clark‐Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652
Self-citationA highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
Current protocols in immunology
Nezlin, R. S. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,413
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K. B., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,378
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.3.963 · Cited by 1,333
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Pathogenesis of Herpetic Stromal Keratitis in CCR5- and/or CXCR3-Deficient Mice
Komatsu, K., Miyazaki, D., Morohoshi, K., Kuo, C., 柿丸, 晶., Komatsu, N., Namba, S., Haino, M., Matsushima, K., & Inoue, Y. (2008) · Current Eye Research · doi:10.1080/02713680802344716 · Cited by 19
Trypanosoma cruzi and Chagas Disease: Innate Immunity, ROS, and Cardiovascular System
Tanowitz, H. B., Jian-jun, W., Machado, F. S., Desruisseaux, M. S., Robello, C., & Garg, N. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801078-5.00014-5 · Cited by 19
Edvardsen, K. S. W., Bjanesoy, T. E., Hellesen, A., Breivik, L., Bakke, M., Husebye, E. S., & Bratland, E. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0171 · Cited by 19
CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes
Fallahi, P., Corrado, A., Domenicantonio, A. D., Frenzilli, G., Antonelli, A., & Ferrari, S. M. (2016) · Current Drug Targets · doi:10.2174/1389450115666141229153949 · Cited by 19
Young, C. A., Rorke, E. A., Adhikary, G., Xu, W., & Eckert, R. L. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.238 · Cited by 19
Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation
Jackson, S. E., Chen, K. C., Groves, I. J., Sedikides, G. X., Gandhi, A., Houldcroft, C. J., Poole, E. L., Montanuy, I., Mason, G. M., Okecha, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.657945 · Cited by 19
Andrews, S. H., Klinker, M. W., Bauer, S. R., & Marklein, R. A. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27974 · Cited by 22
Human Cytomegalovirus Infection in Lung Transplant Recipients Triggers a CXCL-10 Response
Weseslindtner, L., Nachbagauer, R., Kundi, M., Jaksch, P., Kerschner, H., Simon, B., Hatos-Agyi, L., Scheed, A., Aberle, J. H., Klepetko, W., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03404.x · Cited by 19
Discovery of potent and specific CXCR3 antagonists
Chen, X., Mihalic, J., Deignan, J., Gustin, D. J., Duquette, J., Du, X., Chan, J., Fu, Z., Johnson, M., Li, A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.120 · Cited by 19
Jhang, W. K., Kang, M., Jin, H., Yu, J., Kim, B., Kim, B. S., Lee, J., Seo, E., Yoo, H., Park, I. S., et al. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9218-z · Cited by 19
Takeuchi, A., Usui, Y., Takeuchi, M., Hattori, T., Kezuka, T., Suzuki, J., Okunuki, Y., Iwasaki, T., Haino, M., Matsushima, K., et al. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1429 · Cited by 19
T Cell Phenotypes of the Normal Nasal Mucosa: Induction of Th2 Cytokines and CCR3 Expression by IL-4
Till, S. J., Jopling, L. A., Wachholz, P. A., Robson, R. L., Qin, S., Andrew, D. P., Wu, L., van Neerven, R. J. J., Williams, T. J., Durham, S. R., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2303 · Cited by 19
Self-citationSato, K., Kawasaki, H., Morimoto, C., Yamashima, N., & Matsuyama, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6263 · Cited by 19
Chemokine-Directed Strategies to Attenuate Allograft Rejection
Schenk, A. D., Rosenblum, J., & Fairchild, R. L. (2008) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2008.07.004 · Cited by 19
Pathogenic T‐Cell Recruitment into the Airway in Human Disease
Medoff, B. D., Thomas, S. Y., Banerji, A., Wain, J. C., Zhang, H., Lilly, C. M., Ginns, L. C., & Luster, A. D. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.026 · Cited by 20
Synthesis and structure–activity relationship of benzetimide derivatives as human CXCR3 antagonists
Bongartz, J., Buntinx, M., Coesemans, E., Hermans, B., Lommen, G. V., & Wauwe, J. V. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.115 · Cited by 19
In Situ Study of Chemokine and Chemokine-Receptor Expression in Kaposi Sarcoma
Uccini, S., Scarpino, S., Ballarini, F., Soriani, A., Chilosi, M., Montesu, M. A., Masala, M. V., Cottoni, F., & Ruco, L. (2003) · American Journal of Dermatopathology · doi:10.1097/00000372-200310000-00003 · Cited by 19
Kwun, J., Hu, H., Schadde, E., Roenneburg, D. A., Sullivan, K. A., DeMartino, J. A., Burlingham, W. J., & Knechtle, S. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8016 · Cited by 19
Designing small molecule CXCR3 antagonists
Pease, J. E. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1268597 · Cited by 18
Fettig, N. M., Robinson, H. G., Allanach, J. R., Davis, K. M., Simister, R. L., Wang, E. J., Sharon, A. J., Ye, J., Popple, S., Seo, J. H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111328 · Cited by 19
Patyka, M., Malamud, D., Weissman, D., Abrams, W. R., & Kurago, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132942 · Cited by 18
Hilda, J. N., Selvaraj, A., & Das, S. D. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.01025.x · Cited by 18
Moura, A. S., Carmo, R. A., Teixeira, A. L., Leite, V. H. R., & Rocha, M. O. D. C. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0981-4 · Cited by 18
Urinary biomarkers of renal transplant outcome
Ho, J., Rush, D. N., & Nickerson, P. W. (2015) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000208 · Cited by 18
Fonseka, C. Y., Rao, D. A., & Raychaudhuri, S. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.08.005 · Cited by 18
Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome
Dijck, A. V., Barbosa, S., Bermudez-Martin, P., Khalfallah, O., Gilet, C., Martinuzzi, E., Elinck, E., Kooy, R. F., Glaichenhaus, N., & Davidovic, L. (2020) · BMC Neurology · doi:10.1186/s12883-020-01715-2 · Cited by 18
Niu, F., Liao, K., Hu, G., Moidunny, S., Roy, S., & Buch, S. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.724970 · Cited by 18
Long-Term Exposure of Chemokine CXCL10 Causes Bronchiolitis-like Inflammation
Jiang, D., Liang, J., Guo, R., Xie, T., Kelly, F. L., Martinu, T., Yang, T., Lovgren, A. K., Chia, J. Y., Liu, N., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0116oc · Cited by 18
Crescioli, C. (2014) · BioMed Research International · doi:10.1155/2014/949730 · Cited by 18
Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production
Brenndörfer, E. D., Braß, A., Söderholm, J., Frelin, L., Aleman, S., Bode, J. G., & Sällberg, M. (2011) · Gut · doi:10.1136/gut.2010.232116 · Cited by 18
Ohta, K., Naruse, T., Kato, H., Ishida, Y., Nakagawa, T., Ono, S., Shigeishi, H., & Takechi, M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7432 · Cited by 18
New Drug Targets in Rheumatoid Arthritis
Shadidi, K. R. (2004) · BioDrugs · doi:10.2165/00063030-200418030-00004 · Cited by 18
Mehmut, M., Takeda, K., Abe, M., Ogata, H., Hirose, S., Okumura, K., & Fujime, Μ. (2005) · Urologia Internationalis · doi:10.1159/000085934 · Cited by 18
JO, Y., MATSUMOTO, T., Yada, S., Fujisawa, K., Esaki, M., Onai, N., MATSUSHIMA, K., & Iida, M. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02155.x · Cited by 18
Jopling, L. A., Sabroe, I., Andrew, D. P., Mitchell, T. J., Li, Y., Hodge, M. R., Williams, T. J., & Pease, J. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109974200 · Cited by 18
An introduction to chemokines and their roles in transfusion medicine
Davenport, R. (2008) · Vox Sanguinis · doi:10.1111/j.1423-0410.2008.01127.x · Cited by 18
Interleukin-8 and other CXC chemokines
Mukaida, N., Ketlinsky, S. A., & Matsushinur, K. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50050-8 · Cited by 18
Δ32 Mutation of the Chemokine-Receptor 5 Gene in Inflammatory Bowel Disease
Martin, K., Heinzlmann, M., Borchers, R., Mack, M., Loeschke, K., & Folwaczny, C. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4943 · Cited by 18
Handel, M. L., & Girgis, L. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0186 · Cited by 18
Münch, C., Upadhaya, B. P., Rayamajhee, B., Adhikari, A., Münch, M., En-Nosse, N., Kowalski, K., Eickmann, M., Bauer, C. A., Manandhar, K. D., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.12.022 · Cited by 17
Hinnerskov, J. M. V., Nielsen, M. K., Thomsen, A. K., Steffensen, M. A., Honoré, B., Vorum, H., Nissen, M. H., & Sørensen, T. L. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.1.5 · Cited by 17
Nair, A. G., Wong, M., Shu, Y., Jiang, Y., Jenh, C., Kim, S. H., Yang, D., Zeng, Q., Shao, Y., Zawacki, L. G., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.01.009 · Cited by 17
Monitoring peri-operative immune suppression in renal cancer patients
Riemann, D. (2011) · Oncology Reports · doi:10.3892/or.2011.1199 · Cited by 17
Hofer, M. J., Carter, S. L., Müller, M., & Campbell, I. L. (2008) · Viral Immunology · doi:10.1089/vim.2008.0057 · Cited by 17
Martens, H. A., GROSS, S., van der Steege, G., Brouwer, E., Berden, J. H. M., de Sévaux, R. G. L., Derksen, R. H. W. M., Voskuyl, A. E., Berger, S. P., Navis, G., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091468 · Cited by 17
Primary biliary cirrhosis: From bench to bedside
Kouroumalis, E. (2015) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v6.i3.32 · Cited by 17
Expression of Interferon-Gamma-Inducible Protein-10 and Its Receptor CXCR3 in Chronic Pancreatitis
Singh, L., Bakshi, D. K., Majumdar, S., Vasishta, R. K., Arora, S. K., & Wig, J. D. (2007) · Pancreatology · doi:10.1159/000108965 · Cited by 17
Assessment of contact allergen cross‐reactivity by retesting
Rustemeyer, T., de Groot, J., Blomberg, B. M. E. V., Bruynzeel, D. P., Frosch, P. J., & Scheper, R. J. (2002) · Experimental Dermatology · doi:10.1034/j.1600-0625.2001.110309.x · Cited by 17
Early inflammatory markers in elicitation of allergic contact dermatitis
Martín, A., Gallino, N., Gagliardi, J., Ortiz, S. G., Lascano, A. R., Diller, A., Daraio, M. C., Kahn, A. M., Mariani, A. L., & Serra, H. M. (2002) · BMC Dermatology · doi:10.1186/1471-5945-2-9 · Cited by 17
DOCK8 Expression in Regulatory T Cells Maintains their Stability and Limits Contact Hypersensitivity
Wilkie, H., Janssen, E., Leyva-Castillo, J. M., & Geha, R. S. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.09.027 · Cited by 16
Kochumon, S., Al-Sayyar, A., JACOB, T. K., Hasan, A., Al‐Mulla, F., Sindhu, S. T. A. K., & Ahmad, R. (2021) · Biomolecules · doi:10.3390/biom11091355 · Cited by 16
Meyer, E. A., Äänismaa, P., Ertel, E. A., Huehn, E., Strasser, D. S., Rey, M., Murphy, M., Martinic, M. M. A., Pouzol, L., Froidevaux, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00074 · Cited by 16
Garcia, G., Humbert, M. J. C., Capel, F., Rimaniol, A., Escourrou, P., Émilie, D., & Godot, V. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01216.x · Cited by 16
Lee, Y. H., Bae, S., & Song, G. G. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0665-2 · Cited by 16
Saha, P. K., Sharma, P. K., Sharma, S. K., Singh, A. R., & Mitra, D. K. (2013) · Cytokine · doi:10.1016/j.cyto.2013.04.001 · Cited by 16
Muramatsu, M., Gao, L., Peresie, J., Balderman, B., Akakura, S., & Gelman, I. H. (2017) · Oncotarget · doi:10.18632/oncotarget.20092 · Cited by 16
Torres‐Ruesta, A., Teo, T., Chan, Y., Rénia, L., & Ng, L. F. P. (2019) · Immunological Reviews · doi:10.1111/imr.12825 · Cited by 16
Discovery of a novel series of CXCR3 antagonists
Crosignani, S., Missotten, M., Cleva, C., Dondi, R., Ratinaud, Y., Humbert, Y., Mandal, A. B., Bombrun, A., Power, C., Chollet, A., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.113 · Cited by 16
Holst, P. J., Ørskov, C., Qvortrup, K., Christensen, J. P., & Thomsen, A. R. (2007) · Journal of Virology · doi:10.1128/jvi.01242-07 · Cited by 16
Harada, K. (2002) · Hepatology Research · doi:10.1016/s1386-6346(02)00091-8 · Cited by 16
Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis
Isozaki, T., Amin, M. A., Arbab, A. S., Koch, A. E., Ha, C. M., Edhayan, G., Haines, G. K., & Ruth, J. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4507 · Cited by 16
Self-citationTrifilo, M. J., & Lane, T. E. (2003) · Journal of NeuroVirology · doi:10.1080/13550280390201029 · Cited by 16
Chen, K., Wei, Y., Alter, A., Sharp, G. C., & Braley‐Mullen, H. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205102 · Cited by 16
Llorca, T., Ruiz-Magaña, M. J., Martínez-Aguilar, R., García-Valdeavero, O. M., Rodríguez-Doña, L., Abadía‐Molina, A. C., Ruiz‐Ruiz, C., & Olivares, E. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223539 · Cited by 15
Vascular Responses to Pathogens
(2015) · Elsevier eBooks · doi:10.1016/c2013-0-15546-8 · Cited by 15
Decreased percentage of CD4+ lymphocytes expressing chemokine receptors in bipolar disorder
Barbosa, I. G., Rocha, N. P., Vieira, E. L., Camkurt, M. A., Huguet, R. B., Guimarães, F. T. L., de Brito-Melo, G. E., Mendonça, V. A., Bauer, M. E., & Teixeira, A. L. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.5 · Cited by 15
Hellesen, A., Edvardsen, K., Breivik, L., Husebye, E. S., & Bratland, E. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12291 · Cited by 15
Avula, L. R., Knapen, D., Buckinx, R., Vergauwen, L., Adriaensen, D., Nassauw, L. V., & Timmermans, J. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-377 · Cited by 15
Altered Th1/Th2 commitment contributes to lung senescence in CXCR3-deficient mice
Huang, J., Li, Z., Yao, X., Li, Y., Reng, X., Li, J., Wang, W., Gao, J., Wang, C., Tankersley, C. G., et al. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.04.001 · Cited by 15
Cytokines and Chemokines inMycobacterium tuberculosisInfection
Domingo-Gonzalez, R., Prince, O. A., Cooper, A. M., & Khader, S. A. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch2 · Cited by 15
Liu, Y.-S., Tsai, P.-W., Wang, Y., Fan, T.-C., Hsieh, C., Chang, M. D., Pai, T., Huang, C.-F., Lan, C., & Chang, H. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-105 · Cited by 15
Takama, Y., Miyagawa, S., Yamamoto, A., Firdawes, S., Ueno, T., Ihara, Y., Kondo, A., Matsunami, K., Otsuka, H., & Fukuzawa, M. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.04.003 · Cited by 15
Tissue targeting and disease patterns in systemic vasculitis
Cid, M. C., & Vilardell, C. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0143 · Cited by 15
CXCR3 inhibitors for therapeutic interventions: current status and perspectives
Huo, R., Jiang, Y., Zhang, L., Du, S., & Zhou, D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1556196 · Cited by 14
Inamo, J., Fierkens, R., Clay, M. R., Jonsson, A. H., Lin, C., Hayes, K., Rogers, N. D., Leach, H., & Yomogida, K. (2025) · JCI Insight · doi:10.1172/jci.insight.198074 · Cited by 15
IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways
Liu, L., Cheng, Y. H., Zhang, F., Chen, J., Tian, P., Shi, W., Fei, Z., Yang, M., Zhou, M., & Liu, B. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04509-w · Cited by 14
Hensel, M. T., Peng, T., Cheng, A., Rosa, S. C. D., Wald, A., Laing, K. J., Jing, L., Dong, L., Magaret, A., & Koelle, D. M. (2017) · Journal of Virology · doi:10.1128/jvi.00810-17 · Cited by 14
Stroukov, W., Mastronicola, D., Albany, C. J., Catak, Z., Lombardi, G., & Scottà, C. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24720 · Cited by 14
Silveira, G. F., Strottmann, D. M., de Borba, L., Mansur, D. S., Zanchin, N. I. T., Bordignon, J., & dos Santos, C. N. D. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12701 · Cited by 14
Lam, K., Chu, Y., Kuo, C., Wang, W.-L., Tok, T., Chin, Y., Chen, S. C., & Hung, C. (2010) · Inflammation · doi:10.1007/s10753-010-9229-9 · Cited by 14
Shimizu, S., Yoshinouchi, T., Niimi, T., Ohtsuki, Y., Fujita, J., 前田, 浩., Sato, S., Yamadori, I., Eimoto, T., & Ueda, R. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-006-0330-2 · Cited by 14
Polymorphisms of RANTES and IL-4 Genes in Cerebral Infarction
Um, J., & Kim, H. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9047-9 · Cited by 14
Preventive effects of (5R)-5-hydroxytriptolide on concanavalin A-induced hepatitis
Zhou, R., Tang, W., Ren, Y., He, P., Yang, Y., Li, Y., & Zuo, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.013 · Cited by 14
Immunization Associated with Erectile Dysfunction Based on Cross-Sectional and Genetic Analyses
Chen, Y., Xin, X., Zhang, H., Xu, J., Gao, Y., Tan, A., Yang, X., Qin, X. Y., Hu, Y., & Mo, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111269 · Cited by 14
Quinones, M. P., Jiménez, F., Martinez, H. G., Estrada, C. A., Willmon, O., Dudley, M., Kuziel, W. A., Melby, P. C., Reddick, R. L., Ahuja, S. K., et al. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0039-3 · Cited by 14
Calabresi, P. A., Allie, R., Mullen, K. M., Yun, S. H., Georgantas, R. W., & Whartenby, K. A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00127-9 · Cited by 14
Patel, D. D., & Haynes, B. F. (2000) · KARGER eBooks · doi:10.1159/000060517 · Cited by 14
In vivo stability of human chemokine and chemokine receptor expression
Campbell, J. D., Stinson, M. J., Simons, F. E. R., Rector, E. S., & HayGlass, K. T. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00260-9 · Cited by 14
Hatse, S., Huskens, D., Princen, K., Vermeire, K., Bridger, G. J., Clercq, E. D., ROSENKILDE, M. M., Schwartz, T. W., & Schols, D. (2007) · Journal of Virology · doi:10.1128/jvi.01941-06 · Cited by 14
Medina, J. C., Johnson, M. G., & Collins, T. L. (2005) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(05)40014-7 · Cited by 14
Activation of the Ras-related GTPase Rap1 by thymocyte TCR engagement and during selection
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200010)30:10 · Cited by 3
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4
Short peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3
Dabhi, V. M., & Fischer Lindahl, K. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11
Self-citationSantiago (2001) · doi:10.1002/1529-0131(200107)44:7
Self-citationKomuro (2001) · doi:10.1002/1529-0131(200112)44:12
Self-citation
Metadata
- Authors
- Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Bern (CH)
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-02-15
- Volume
- 101
- Issue
- 4
- Pages
- 746-754
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508621
- OpenAlex
- W2081596482
- Cited by
- 1,359
- References
- 39
- Citations by year
- 2026: 6 · 2025: 25 · 2024: 11 · 2023: 20 · 2022: 24 · 2021: 33 · 2020: 23 · 2019: 33 · 2018: 32 · 2017: 33 · 2016: 24 · 2015: 46 · 2014: 52 · 2013: 38 · 2012: 45
- FWCI
- 37.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Keywords
- CXCR3, CCR5, chemokine receptors, T cell subsets, T cell homing, inflammatory cell infiltration, Th1 response, CXCL10, RANTES, CCL22, CCL19, CD45RO, beta1 integrin, T cell migration, lymph node T cells
- MeSH terms
- Animals, Antibodies, Monoclonal, Chemotaxis, Humans, Immunologic Memory, Inflammation, Leukocytes, Lymphocyte Activation, Lymphocytes, Mice, Inbred BALB C, Synovial Fluid, Tumor Cells, Cultured, Biomarkers, T-Lymphocyte Subsets, Chemokines, Receptors, Chemokine, Receptors, CCR5, Chemokines, CXC, Mice, Chemokine CXCL10, Receptors, CXCR3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review